{"transactions":[{"id":1488065,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T16:33:31.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 12,500 shares of the Issuer's common stock, and vests in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":12500,"derivative":{"exercise_price":0.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-069927","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017024069927/ownership.xml","form_type":"4"}},{"id":1488064,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T16:33:31.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 12,500 restricted stock units, which vest in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":30746,"source":{"system":"sec-edgar","filing":"0000950170-24-069927","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017024069927/ownership.xml","form_type":"4"}},{"id":1499442,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T23:20:29.000Z","date":"2024-05-25","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":0.9075,"expiration_date":"2034-05-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000905148-24-001653","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514824001653/form4.xml","form_type":"4"}},{"id":1499441,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-29T23:20:29.000Z","date":"2024-05-25","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0000905148-24-001653","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514824001653/form4.xml","form_type":"4"}},{"id":1831084,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T22:45:27.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":1.32,"expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-23-034283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036123034283/form4.xml","form_type":"4"}},{"id":1831083,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-12T22:45:27.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001140361-23-034283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036123034283/form4.xml","form_type":"4"}},{"id":1851416,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:07:35.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 12,500 shares of the Issuer's common stock, and vests in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":12500,"derivative":{"exercise_price":4.7,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-23-028599","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017023028599/ownership.xml","form_type":"4"}},{"id":1851415,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T16:07:35.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 12,500 restricted stock units, which vest in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":18246,"source":{"system":"sec-edgar","filing":"0000950170-23-028599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017023028599/ownership.xml","form_type":"4"}},{"id":2061733,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series X Preferred Stock","published_at":"2023-01-05T16:06:20.000Z","date":"2023-01-03","kind":"disposition_to_issuer","acquired":false,"shares":44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 10, 2022, the Company's board of directors (the \"Board\") declared a dividend of one one-thousandth of a share of Series X Preferred Stock, par value $0.001 per share (the \"Preferred Stock\"), for each outstanding share of common stock to common stockholders of record at 5:00 p.m. Eastern Time on November 21, 2022, in a transaction exempt from Section 16 under Rule 16a-9. The shares of Preferred Stock were distributed on November 21, 2022. As a result, the Reporting Person received the shares of Preferred Stock set forth above. The Preferred Stock was not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 3, 2023, in connection with the Company's reverse stock split for the common stock, the shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation of the Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.001 in cash (rounded to the nearest cent) for each whole share of Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 3, 2023, in connection with the Company's reverse stock split for the common stock, the shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation of the Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.001 in cash (rounded to the nearest cent) for each whole share of Preferred Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323000970/doc4.xml","form_type":"4"}},{"id":2226708,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T16:31:26.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":148810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F2","text":"This option represents the right to purchase 148,810 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 15, 2023 or (2) the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 148,810 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 15, 2023 or (2) the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":148810,"derivative":{"exercise_price":0.64,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":148810},"source":{"system":"sec-edgar","filing":"0000899243-22-023092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322023092/doc4.xml","form_type":"4"}},{"id":2226707,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T16:31:26.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":96154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 96,154 restricted stock units, which vest in full on the earlier of (1) June 15, 2023 or (2) the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":143672,"source":{"system":"sec-edgar","filing":"0000899243-22-023092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322023092/doc4.xml","form_type":"4"}},{"id":2260443,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T21:50:03.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest monthly over one (1) year from the date of grant subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":2.01,"expiration_date":"2032-05-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-22-020302","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036122020302/form4.xml","form_type":"4"}},{"id":2260442,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-23T21:50:03.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001140361-22-020302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036122020302/form4.xml","form_type":"4"}},{"id":2665579,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T18:03:48.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":51724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F2","text":"This option represents the right to purchase 51,724 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 14, 2022 or (2) the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 51,724 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 14, 2022 or (2) the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":51724,"derivative":{"exercise_price":3.17,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":51724},"source":{"system":"sec-edgar","filing":"0000899243-21-024206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321024206/doc4.xml","form_type":"4"}},{"id":2665578,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T18:03:48.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":29183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 29,183 restricted stock units, which vest in full on the earlier of (1) June 14, 2022 or (2) the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":47518,"source":{"system":"sec-edgar","filing":"0000899243-21-024206","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321024206/doc4.xml","form_type":"4"}},{"id":2701346,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-22T00:59:38.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":3.64,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001179110-21-005768","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911021005768/edgar.xml","form_type":"4"}},{"id":2701345,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-22T00:59:38.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the reporting person's continuous service on the Company's Board of Directors."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001179110-21-005768","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911021005768/edgar.xml","form_type":"4"}},{"id":3147591,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-16T00:53:38.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors."}],"balance_after":55000,"derivative":{"exercise_price":1.765,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001179110-20-006133","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911020006133/edgar.xml","form_type":"4"}},{"id":3512219,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-24T21:19:52.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors."}],"balance_after":55000,"derivative":{"exercise_price":2.02,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001179110-19-006701","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019006701/edgar.xml","form_type":"4"}},{"id":3926191,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-19T01:36:25.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors."}],"balance_after":40000,"derivative":{"exercise_price":3.98,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001179110-18-007153","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018007153/edgar.xml","form_type":"4"}},{"id":4226744,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":90190,"kind":"person","name":"Kotzin Brian L.","position":1,"cik":"0001715332","reported_name":"Kotzin Brian L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-24T00:26:25.000Z","date":"2017-08-21","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option shall vest in equal monthly installments over the shorter of three years from the date of grant or the period beginning on the date the director is appointed to the Board and ending on the date of the annual meeting at which the director is first considered for election by the stockholders, provided that the non-employee director continues to provide services."}],"balance_after":80000,"derivative":{"exercise_price":2.2,"expiration_date":"2027-08-21","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001179110-17-011797","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017011797/edgar.xml","form_type":"4"}}]}